Price of Abemaciclib
The price of Abemaciclib is affected by factors such as specification, region, and medical insurance policy. The monthly cost generally ranges from several thousand yuan, and the actual price shall be subject to the quotation from hospitals or formal pharmacies.
As a prescription drug, it must be used under strict medical advice, and the treatment regimen should be formulated according to the individual patient’s condition.
Factors Affecting Price
Specification and Packaging
Different dosages (e.g., 50mg, 100mg, 150mg) and the number of tablets per box directly affect the total price. For example, the 150mg formulation is usually more expensive than lower‑dose versions.
Region and Channel
Reimbursement policies, hospital procurement prices, and pharmacy retail prices vary by region. Abemaciclib is covered by medical insurance in some cities, significantly reducing patients’ out‑of‑pocket expenses.
Medical Insurance Policy
After the 2023 update of the National Reimbursement Drug List, Abemaciclib has been included in the insurance coverage in some regions. Patients need to provide a doctor’s prescription and diagnosis certificate for reimbursement.
Precautions for Use
Indications
Abemaciclib, in combination with endocrine therapy, is indicated for patients with hormone receptor‑positive, HER2‑negative advanced or metastatic breast cancer.
Side Effect Management
Common adverse reactions include diarrhea, neutropenia, etc. Regular monitoring of blood routine, liver and kidney function is required. Patients should seek medical attention promptly in case of abnormalities.
Contraindications and Cautions
Dose adjustment is required for patients with severe hepatic impairment.
Contraindicated in pregnant women, breastfeeding women, and patients hypersensitive to any ingredient of this product.
Financial Assistance and Support
Patient Assistance Programs
Some pharmaceutical companies or charitable organizations provide drug assistance programs. Eligible patients may apply for partial cost reduction or exemption.
Local Beneficial Policies
Certain cities offer additional subsidies for specific diseases such as malignant tumors. Patients are advised to consult the local medical insurance department or hospital social work department.
Medical and Medication Guidance
Prescription
A prescription must be issued by an oncologist or breast specialist after evaluation. Do not purchase or adjust the dosage without medical advice.
Follow‑up
Regular imaging examinations and tumor marker tests are required during treatment to evaluate efficacy and adjust the regimen.
For further information on pricing or detailed usage instructions, please consult formal medical institutions and strictly follow medical guidance.
